Researchers report IL-33 can reduce memory and cognitive problems associated with Alzheimer's disease within one week of treatment in mice. Additionally, IL-33 can reduce the number and size of amyloid plaques.
Researchers believe they have discovered an elusive drug candidate, a molecule in snake venom, that appears o activate an enzyme involved in breaking down amyloid plaques.
